In fact, while the proportion of any bleeding was higher ( P = 0.006) in the IPE group (11.8%) compared to placebo (9.9%)), the rate of hemorrhagic stroke did not reach statistical significance ( P = 0.54), while serious bleeding events were more frequent in the IPE group (2.7% [111/4089] versus 2.1% [85/4090] in the placebo group, P = 0.06) .
← all excerpts
A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids.
1
0.5400
0.5400